Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 \< 75 years
Ferritin \> 250 ng/ml and/or stainable iron at biopsy
NAS ≥ 2 and/or NAS 1 and stage≥1 at liver histology
Willingness to maintain diet and exercise during the full course of the study
Written informed consent to participate to the study and to have the specific genetic tests performed
Ability to comply with all study requirements
You may not be if
Pregnant or lactating female
Diagnosis of or a history of:
Type 1 diabetes, diabetes that is a result of pancreatic injury, or secondary forms of diabetes, e.g. Cushing's syndrome or acromegaly
Acute metabolic complication such as ketoacidosis or hyperosmolar state within the past 6 months
Alcohol consumption \> 20 g/day for females and \> 30 g/day for males
BMI ≥ 35 Kg/ m2
Other liver disease such as viral hepatitis, autoimmune hepatitis, Wilson disease, as defined by ceruloplasmin below normal limits and liver histology consistent with Wilson disease. Alpha-1-antitrypsin deficiency as defined by alpha-1-antitrypsin level less than 80 mg/dl or PiZ/PiZ or PiZ/PiS genotype. \*Hemochromatosis, as defined by homozygosity for the C282Y HFE mutation or compound heterozygosity for C282Y/H63D mutations or Hepatic Iron Index ≥ 1.9.